Target intelligence / Profile preview

U2AF homology motif kinase 1 (UHMK1)

Target
UHMK1
Molecular classification
Enzyme, Serine/threonine kinase, Splicing regulatory kinase (contains U2AF homology motif; only kinase with UHM domain)
01

Overview

U2AF homology motif kinase 1 (UHMK1) is a unique serine/threonine protein kinase notable for possessing the U2AF homology motif (UHM), typically found in RNA-binding and spliceosomal proteins. UHMK1 regulates key steps in alternative and canonical mRNA splicing by phosphorylating splicing factors such as SF1 and SF3B1. Additionally, it controls cell cycle progression by targeting CDKN1B/p27Kip1 for phosphorylation, influencing cell division and proliferation. UHMK1 is abnormally upregulated in several cancers, contributing to tumor progression and chemoresistance (notably via interaction with STAT3 and PI3K/AKT/mTOR pathways). It is also associated with neurological conditions such as schizophrenia. UHMK1 is actively studied for its role in gene regulation, cell migration, and as a potential therapeutic target in oncology. No selective clinical UHMK1 inhibitors are established as of now.

Other names
Serine/threonine-protein kinase KistUHMK1KISKISTP-CIP2Kinase interacting with stathminPAM COOH-terminal interactor protein 2Kinase interacting with leukemia-associated gene (stathmin)
02

Mechanism of action

Inhibition of UHMK1 kinase activity would block phosphorylation of cell cycle and splicing proteins, potentially reducing cell proliferation and reversing chemoresistance. Targeting UHMK1 can modulate PI3K/AKT/mTOR and IL6/STAT3 signaling pathways, impacting cancer progression

03

Biological functions

RNA splicing (alternative and canonical splicing regulation)Phosphorylation of splicing factors SF1 and SF3B1Cell cycle progression (phosphorylates p27Kip1/CDKN1B)Cell divisionMicrotubule organizationGene expression regulationProtein phosphorylationEpithelial-mesenchymal transitionCell proliferationCell migration
04

Disease associations

Cancer (lung adenocarcinoma, colorectal, gastric, liver, cervical, leukemia)Neurological (schizophrenia)Chemoresistance in cancer
05

Safety considerations

Given involvement in cell cycle and splicing, systemic inhibition could impact normal cell proliferation and splicing, raising potential toxicity risks (e.g., hematologic, neurologic)
06

Biomarkers

Elevated UHMK1 expression in tumor tissue (lung, colorectal, gastric, etc.)Phosphorylation status of p27Kip1 (serine 10)

Beyond the preview

Go deeper on U2AF homology motif kinase 1 (UHMK1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U2AF homology motif kinase 1 (UHMK1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call